Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Pfenex Inc (NYSE MKT LLC:PFNX)

7.76
Delayed Data
As of Aug 24
 -0.58 / -6.95%
Today’s Change
5.79
Today|||52-Week Range
22.24
-37.32%
Year-to-Date
No recent news for Pfenex Inc.

Today’s Trading

Previous close8.34
Today’s open8.22
Day’s range7.74 - 8.36
Volume45,599
Average volume (3 months)78,445
Market cap$181.5M
Dividend yield--
Data as of 08/24/2016

Growth & Valuation

Earnings growth (last year)-21.15%
Earnings growth (this year)-55.56%
Earnings growth (next 5 years)--
Revenue growth (last year)-9.97%
P/E ratioNM
Price/Sales28.91
Price/Book2.54

Competitors

 Today’s
change
Today’s
% change
CBMGCellular Biomedicine...-0.09-0.64%
PTGXProtagonist Therapeu...-0.54-4.70%
ADVMAdverum Biotechnolog...-0.42-9.40%
ENZYEnzymotec Ltd-0.16-1.99%
Data as of 08/24/2016

Financials

Next reporting dateNovember 11, 2016
EPS forecast (this quarter)-$0.57
Annual revenue (last year)$9.6M
Annual profit (last year)-$28.2M
Net profit margin-294.44%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, Secretary &
Class III Director
Bertrand C. Liang
Vice President-
Operations
Henry W. Talbot
Corporate headquarters
San Diego, California

Forecasts

Partner Offers

Search for Jobs